We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Lead Plaintiffs Seek Class Certification In Securities Suit Against Drug Maker

(July 14, 2017, 1:31 PM EDT) -- BOSTON — A federal judge should grant a motion for class certification filed by lead plaintiffs in a securities class action lawsuit against a biopharmaceutical company and certain of its executive...
To view the full article, register now.